The USP24 Protein (Ubiquitin-Specific Protease 24) is a large deubiquitinating enzyme belonging to the USP family of cysteine proteases. With a molecular weight of approximately 262 kDa and consisting of 2,071 amino acids, USP24 is one of the larger deubiquitinating enzymes in the human proteome. This page provides comprehensive information about its molecular function, structure, disease associations, and therapeutic implications for neurodegenerative diseases.
Usp24 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
USP24 (Ubiquitin-Specific Protease 24) is encoded by the USP24 gene located on chromosome 9p13.3, a region that has been implicated in various neurological disorders [1]. As a deubiquitinating enzyme (DUB), USP24 plays critical roles in regulating protein stability, signaling pathways, and cellular homeostasis—all processes fundamental to neuronal survival and function.
USP24 possesses a complex multi-domain architecture that enables its diverse functional capabilities:
The three-dimensional structure of USP24 has been predicted through homology modeling, revealing a conserved catalytic core similar to other USP family members, with extended N-terminal regulatory regions that likely confer substrate specificity [4].
USP24 is a member of the ubiquitin-specific protease (USP) subfamily of deubiquitinating enzymes that catalyze the removal of ubiquitin from substrate proteins. This reversible modification regulates numerous cellular processes:
USP24 has been identified as a risk gene for Parkinson's disease (PD) through genome-wide association studies (GWAS) [10][11]. The chromosome 9p13.3 locus containing USP24 shows consistent association with sporadic PD risk across multiple ethnic populations. The mechanism likely involves:
A meta-analysis of over 13,000 PD cases and controls confirmed the association, with an odds ratio of approximately 1.12 for the risk allele [14].
Emerging evidence suggests a role for USP24 in Alzheimer's disease (AD) pathogenesis:
USP24 variants have been implicated in ALS susceptibility:
While not the focus of this wiki, USP24 is frequently amplified in various cancers and may stabilize oncogenic proteins [20][21]. This dual role in cancer and neurodegeneration highlights the importance of precise regulation of deubiquitinating enzymes.
USP24 represents a potential therapeutic target for neurodegenerative diseases:
The study of Usp24 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Lillo P, et al. (2016).ALS and FTD: the therapeutic angle. Nat Rev Neurol. 2016. ↩︎